White Knight Strategic Wealth Advisors, LLC Abb Vie Inc. Transaction History

White Knight Strategic Wealth Advisors, LLC

$97.2 Million
Q2 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $187,963 - $225,417	1,359 New	1,359 $220,000

Others Institutions Holding ABBV

# of Institutions

3,795

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$29.8 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$23.8 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$13.6 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$9.09 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$6.73 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $308B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of White Knight Strategic Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on White Knight Strategic Wealth Advisors, LLC with notifications on news.

Account